医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

SAS统计软件的使用

2018-04-11 MedSci MedSci原创

科研基金
关注

SAS统计软件的使用图1.SAS操作界面

SAS统计软件的使用




图1.SAS操作界面


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2075783, encodeId=a28920e5783d2, content=<a href='/topic/show?id=8948e895323' target=_blank style='color:#2F92EE;'>#统计软件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78953, encryptionId=8948e895323, topicName=统计软件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Mar 01 21:58:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007776, encodeId=7741200e776e4, content=<a href='/topic/show?id=cf4d1590956' target=_blank style='color:#2F92EE;'>#SAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15909, encryptionId=cf4d1590956, topicName=SAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Dec 19 06:58:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304800, encodeId=cf0330480009, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:16 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2019-03-01 huangshifeng

    #统计软件#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2075783, encodeId=a28920e5783d2, content=<a href='/topic/show?id=8948e895323' target=_blank style='color:#2F92EE;'>#统计软件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78953, encryptionId=8948e895323, topicName=统计软件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Mar 01 21:58:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007776, encodeId=7741200e776e4, content=<a href='/topic/show?id=cf4d1590956' target=_blank style='color:#2F92EE;'>#SAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15909, encryptionId=cf4d1590956, topicName=SAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Dec 19 06:58:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304800, encodeId=cf0330480009, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:16 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-12-19 jiyangfei

    #SAS#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2075783, encodeId=a28920e5783d2, content=<a href='/topic/show?id=8948e895323' target=_blank style='color:#2F92EE;'>#统计软件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78953, encryptionId=8948e895323, topicName=统计软件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Fri Mar 01 21:58:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007776, encodeId=7741200e776e4, content=<a href='/topic/show?id=cf4d1590956' target=_blank style='color:#2F92EE;'>#SAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15909, encryptionId=cf4d1590956, topicName=SAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Wed Dec 19 06:58:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304800, encodeId=cf0330480009, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Wed Apr 11 15:27:16 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-11 龙胆草

    学习谢谢分享

    0

相关资讯

SCI写作之结果

SCI写作之结果图1.RCT研究患者招募流程图 图2.基线资料表图3.疗效表格图4.安全性表格图5.患者招募流程图RCT研究的结局有主要终点和次要终点之分，研究终点有几种形式，见下表

SCI写作之前言

SCI写作之前言以上就是对SCI写作前言部分的知识和技巧分享，并希望大家能够有所收获，下一期，我们将继续介绍SCI写作的方法学部分内容，敬请期待！

非随机对照试验报告规范——TREND规范简介

TREND规范简介以上就是非随机对照研究写作规范TREND Checklist的内容，需要注意的是，TREND规范只适用于采用非随机设计的关于干预效果评价的研究，并不适用于所有的非随机试验研究。希望大家通过本节的介绍，了解并严格按照TREND规范内容进行非随机对照研究报告的撰写。

SCI写作之方法

科研基金

CONSORT规范简介

CONSORT规范简介

STROBE规范简介

STROBE规范简介